Literature DB >> 31176716

Tetramethylenedisulfotetramine neurotoxicity: What have we learned in the past 70 years?

Marcela Lauková1, Jana Velíšková2, Libor Velíšek3, Michael P Shakarjian4.   

Abstract

Tetramethylenedisulfotetramine (tetramine, TETS, TMDT) is a seizure-producing neurotoxic chemical formed by the condensation of sulfamide and formaldehyde. Serendipitously discovered through an occupational exposure in 1949, it was promoted as a rodenticide but later banned worldwide due to its danger to human health. However, exceptional activity of the agent against rodent pests resulted in its clandestine manufacture with large numbers of inadvertent, intentional, and mass poisonings, which continue to this day. Facile synthesis, extreme potency, persistence, lack of odor, color, and taste identify it as an effective food adulterant and potential chemical agent of terror. No known antidote or targeted treatment is currently available. In this review we examine the origins of tetramethylenedisulfotetramine, from its identification as a neurotoxicant 70 years ago, through early research, to the most recent findings including the risk it poses in the post-911 world. Included is the information known regarding its in vitro pharmacology as a GABAA receptor channel antagonist, the toxic syndrome it produces in vivo, and its effect upon vulnerable populations. We also summarize the available information about potential therapeutic countermeasures and treatment strategies as well as the contribution of clinical development of TMDT poisoning to our understanding of epileptogenesis. Finally we identify gaps in our knowledge and suggest potentially fruitful directions for continued research on this dangerous, yet intriguing compound.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Countermeasures; Neurotoxicology; Pharmacotherapy; Seizures; Terrorism; Tetramethylenedisulfotetramine; Vulnerable populations

Year:  2019        PMID: 31176716      PMCID: PMC6895414          DOI: 10.1016/j.nbd.2019.104491

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  75 in total

1.  Reduction of tetramine toxicity by sedatives and anticonvulsants.

Authors:  E VOSS; A R HASKELL; L GARTENBERG
Journal:  J Pharm Sci       Date:  1961-10       Impact factor: 3.534

2.  The CounterACT Research Network: basic mechanisms and practical applications.

Authors:  David A Jett; David T Yeung
Journal:  Proc Am Thorac Soc       Date:  2010-07

3.  Tetramine poisoning.

Authors:  C M Chau; A K H Leung; I K S Tan
Journal:  Hong Kong Med J       Date:  2005-12       Impact factor: 2.227

4.  Influence of tetramethylenedisulfotetramine on synchronous calcium oscillations at distinct developmental stages of hippocampal neuronal cultures.

Authors:  Zhengyu Cao; Jian Xu; Susan Hulsizer; Yanjun Cui; Yao Dong; Isaac N Pessah
Journal:  Neurotoxicology       Date:  2016-10-29       Impact factor: 4.294

5.  Rates of motor seizure development in rats subjected to electrical brain stimulation: strain and inter-stimulation interval effects.

Authors:  R J Racine; W M Burnham; J G Gartner; D Levitan
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1973-11

6.  GABAA receptor and cell membrane potential as functional endpoints in cultured neurons to evaluate chemicals for human acute toxicity.

Authors:  Mireia Galofré; Zoila Babot; Daniel A García; Susana Iraola; Eduard Rodríguez-Farré; Anna Forsby; Cristina Suñol
Journal:  Neurotoxicol Teratol       Date:  2009-02-10       Impact factor: 3.763

7.  Behavioral intoxication following voluntary oral ingestion of tetramethylenedisulfotetramine: Dose-dependent onset, severity, survival, and recovery.

Authors:  Nathaniel C Rice; Noah A Rauscher; Jeffrey L Langston; Todd M Myers
Journal:  Neurotoxicology       Date:  2017-09-07       Impact factor: 4.294

8.  Status epilepticus from an illegally imported Chinese rodenticide: "tetramine".

Authors:  Fermin Barrueto; Peter M Furdyna; Robert S Hoffman; Robert J Hoffman; Lewis S Nelson
Journal:  J Toxicol Clin Toxicol       Date:  2003

9.  Two types of cage convulsant action at the GABA-gated chloride channel.

Authors:  C J Palmer; J E Casida
Journal:  Toxicol Lett       Date:  1988-08       Impact factor: 4.372

10.  Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. II. The effects of MK-801.

Authors:  L Velísek; S Veresová; H Pôbisová; P Mares
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more
  6 in total

1.  Susceptibility of larval zebrafish to the seizurogenic activity of GABA type A receptor antagonists.

Authors:  Suren B Bandara; Dennis R Carty; Vikrant Singh; Danielle J Harvey; Natalia Vasylieva; Brandon Pressly; Heike Wulff; Pamela J Lein
Journal:  Neurotoxicology       Date:  2019-12-04       Impact factor: 4.294

2.  Preface: Discovery and development of better medical countermeasures for chemical threats targeting the nervous system.

Authors:  David A Jett; Aristea S Galanopoulou; Solomon L Moshé
Journal:  Neurobiol Dis       Date:  2019-07-30       Impact factor: 5.996

3.  Structure-Activity Relationship of Neuroactive Steroids, Midazolam, and Perampanel Toward Mitigating Tetramine-Triggered Activity in Murine Hippocampal Neuronal Networks.

Authors:  Shane Antrobus; Brandon Pressly; Atefeh Mousavi Nik; Heike Wulff; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2021-04-12       Impact factor: 4.849

4.  Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam.

Authors:  Dorota Zolkowska; Ashish Dhir; Michael A Rogawski
Journal:  Arch Toxicol       Date:  2021-04-29       Impact factor: 5.153

5.  Comparison of the toxicokinetics of the convulsants picrotoxinin and tetramethylenedisulfotetramine (TETS) in mice.

Authors:  Brandon Pressly; Natalia Vasylieva; Heike Wulff; Bogdan Barnych; Vikrant Singh; Latika Singh; Donald A Bruun; Sung Hee Hwang; Yi-Je Chen; James C Fettinger; Stephanie Johnnides; Pamela J Lein; Jun Yang; Bruce D Hammock
Journal:  Arch Toxicol       Date:  2020-04-01       Impact factor: 5.153

6.  Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α 2 β 3 γ 2 GABAA Receptor.

Authors:  Brandon Pressly; Ruth D Lee; Bogdan Barnych; Bruce D Hammock; Heike Wulff
Journal:  Mol Pharmacol       Date:  2020-10-27       Impact factor: 4.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.